| 1 |
34472720 |
10.1002/cnr2.1545 |
2022 |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. |
CCND3 |
| 2 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
CCND3 |
| 3 |
34617271 |
10.1111/bjh.17874 |
2022 |
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. |
CCND3 |
| 4 |
35359039 |
10.3760/cma.j.cn112151-20210904-00647 |
2022 |
[Clinicopathological and molecular genetic features of cyclin D1-negative mantle cell lymphoma]. |
CCND3 |
| 5 |
35687490 |
10.1182/bloodadvances.2021006654 |
2022 |
Genomic characterization of lymphomas in patients with inborn errors of immunity. |
CCND3 |
| 6 |
35794096 |
10.1038/s41467-022-31355-8 |
2022 |
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. |
CCND3 |
| 7 |
35982976 |
10.3389/fonc.2022.934008 |
2022 |
Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation. |
CCND3 |
| 8 |
33122824 |
10.1038/s41388-020-01532-4 |
2021 |
Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3. |
CCND3 |
| 9 |
33332554 |
10.1084/jem.20201699 |
2021 |
Cyclin D3 drives inertial cell cycling in dark zone germinal center B cells. |
CCND3 |
| 10 |
33399078 |
10.1016/j.esmoop.2020.100012 |
2021 |
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence. |
CCND3 |
| 11 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
CCND3 |
| 12 |
34114641 |
10.14670/HH-18-351 |
2021 |
The pathologic diagnosis of mantle cell lymphoma. |
CCND3 |
| 13 |
34627430 |
10.19746/j.cnki.issn.1009-2137.2021.05.019 |
2021 |
[Clinical Characteristics and Prognosis Affecting-Factors of the Patients with Burkitt Lymphoma]. |
CCND3 |
| 14 |
31688139 |
10.1097/PAS.0000000000001390 |
2020 |
Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study. |
CCND3 |
| 15 |
31773249 |
10.1007/s00428-019-02704-8 |
2020 |
Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. |
CCND3 |
| 16 |
31849147 |
10.1111/cas.14286 |
2020 |
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas. |
CCND3 |
| 17 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
CCND3 |
| 18 |
32449435 |
10.1080/15476286.2020.1772559 |
2020 |
Burkitt lymphoma-related <i>TCF3</i> mutations alter TCF3 alternative splicing by disrupting hnRNPH1 binding. |
CCND3 |
| 19 |
32738175 |
10.1002/hon.2784 |
2020 |
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis. |
CCND3 |
| 20 |
33207194 |
10.1016/j.celrep.2020.108403 |
2020 |
Cyclin D3 Governs Clonal Expansion of Dark Zone Germinal Center B Cells. |
CCND3 |
| 21 |
30538135 |
10.1182/blood-2018-07-862151 |
2019 |
<i>CCND2</i> and <i>CCND3</i> hijack immunoglobulin light-chain enhancers in cyclin D1<sup>-</sup> mantle cell lymphoma. |
CCND3 |
| 22 |
30733272 |
10.3324/haematol.2018.207928 |
2019 |
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. |
CCND3 |
| 23 |
31557894 |
10.3390/cancers11101427 |
2019 |
FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. |
CCND3 |
| 24 |
29071477 |
10.1007/s12185-017-2360-8 |
2018 |
Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion. |
CCND3 |
| 25 |
29295643 |
10.1080/10428194.2017.1413186 |
2018 |
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. |
CCND3 |
| 26 |
30381403 |
10.1182/bloodadvances.2018019398 |
2018 |
Recurrent <i>CCND3</i> mutations in <i>MLL</i>-rearranged acute myeloid leukemia. |
CCND3 |
| 27 |
27493231 |
10.1136/jim-2016-000233 |
2017 |
Restoration of microRNA-212 causes a G0/G1 cell cycle arrest and apoptosis in adult T-cell leukemia/lymphoma cells by repressing CCND3 expression. |
CCND3 |
| 28 |
27668411 |
10.1002/ijc.30444 |
2017 |
Synergy of interleukin 10 and toll-like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis. |
CCND3 |
| 29 |
28148900 |
10.18632/oncotarget.14846 |
2017 |
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling. |
CCND3 |
| 30 |
28209658 |
10.3324/haematol.2016.156885 |
2017 |
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols. |
CCND3 |
| 31 |
28883003 |
10.1158/0008-5472.CAN-16-2691 |
2017 |
Discovery of Human-Similar Gene Fusions in Canine Cancers. |
CCND3 |
| 32 |
26522721 |
10.1038/onc.2015.385 |
2016 |
ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway. |
CCND3 |
| 33 |
26647218 |
10.1158/1078-0432.CCR-15-2123 |
2016 |
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. |
CCND3 |
| 34 |
26887776 |
10.1111/bjh.13925 |
2016 |
Genetic differences between paediatric and adult Burkitt lymphomas. |
CCND3 |
| 35 |
27440511 |
10.1373/clinchem.2016.255315 |
2016 |
Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma. |
CCND3 |
| 36 |
27750045 |
10.1016/j.ajpath.2016.07.027 |
2016 |
B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains. |
CCND3 |
| 37 |
27888884 |
10.1016/j.hoc.2016.07.009 |
2016 |
Update on Burkitt Lymphoma. |
CCND3 |
| 38 |
27959929 |
10.1371/journal.pmed.1002197 |
2016 |
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. |
CCND3 |
| 39 |
25529125 |
10.1016/j.humpath.2014.10.021 |
2015 |
Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. |
CCND3 |
| 40 |
25704763 |
10.1002/ijc.29494 |
2015 |
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. |
CCND3 |
| 41 |
25839159 |
10.18632/oncotarget.3378 |
2015 |
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma. |
CCND3 |
| 42 |
26173642 |
10.1002/gcc.22268 |
2015 |
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma. |
CCND3 |
| 43 |
26485640 |
10.1016/j.yexcr.2015.10.012 |
2015 |
MicroRNA library screening identifies growth-suppressive microRNAs that regulate genes involved in cell cycle progression and apoptosis. |
CCND3 |
| 44 |
24345752 |
10.1182/blood-2013-10-531509 |
2014 |
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. |
CCND3 |
| 45 |
24492847 |
10.1101/cshperspect.a014282 |
2014 |
Oncogenic mechanisms in Burkitt lymphoma. |
CCND3 |
| 46 |
23255553 |
10.1182/blood-2012-08-452284 |
2013 |
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. |
CCND3 |
| 47 |
23422111 |
NA |
2013 |
Prognostic value of clinical characteristics and immunophenotypic biomarkers in 115 patients with primary central nervous system lymphoma. |
CCND3 |
| 48 |
21479697 |
10.1007/s12032-011-9937-5 |
2012 |
The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. |
CCND3 |
| 49 |
22514694 |
10.1371/journal.pone.0034975 |
2012 |
3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells. |
CCND3 |
| 50 |
22885699 |
10.1038/nature11378 |
2012 |
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. |
CCND3 |
| 51 |
21504716 |
10.1016/j.cancergencyto.2010.08.016 |
2011 |
CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus. |
CCND3 |
| 52 |
21606168 |
10.3324/haematol.2011.041053 |
2011 |
Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells. |
CCND3 |
| 53 |
21945515 |
10.1016/j.semcancer.2011.09.007 |
2011 |
The complex landscape of genetic alterations in mantle cell lymphoma. |
CCND3 |
| 54 |
21965782 |
NA |
2011 |
Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma. |
CCND3 |
| 55 |
20062012 |
10.1038/modpathol.2009.173 |
2010 |
Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. |
CCND3 |
| 56 |
20107311 |
10.4161/cc.9.4.10783 |
2010 |
Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. |
CCND3 |
| 57 |
20193116 |
10.5732/cjc.009.10552 |
2010 |
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma. |
CCND3 |
| 58 |
20956547 |
10.1084/jem.20091962 |
2010 |
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. |
CCND3 |
| 59 |
19001083 |
10.1182/blood-2008-03-147967 |
2009 |
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. |
CCND3 |
| 60 |
19639271 |
10.1007/s12185-009-0382-6 |
2009 |
Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patients. |
CCND3 |
| 61 |
19704260 |
10.1097/PDM.0b013e31818935d2 |
2009 |
Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue. |
CCND3 |
| 62 |
18382684 |
10.1371/journal.pone.0001911 |
2008 |
p27 deficiency cooperates with Bcl-2 but not Bax to promote T-cell lymphoma. |
CCND3 |
| 63 |
18391076 |
10.1182/blood-2007-10-118794 |
2008 |
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. |
CCND3 |
| 64 |
18685613 |
10.1038/leu.2008.213 |
2008 |
Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. |
CCND3 |
| 65 |
17300668 |
10.1111/j.1440-1827.2006.02058.x |
2007 |
Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma. |
CCND3 |
| 66 |
16122798 |
10.1016/j.leukres.2005.06.025 |
2006 |
Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. |
CCND3 |
| 67 |
16614728 |
10.1038/sj.jid.5700224 |
2006 |
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. |
CCND3 |
| 68 |
15389259 |
10.1038/modpathol.3800276 |
2005 |
Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma. |
CCND3 |
| 69 |
15665120 |
10.1182/blood-2003-07-2558 |
2005 |
Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. |
CCND3 |
| 70 |
16123218 |
10.1182/blood-2005-04-1753 |
2005 |
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. |
CCND3 |
| 71 |
16218953 |
10.1111/j.1742-4658.2005.04918.x |
2005 |
Analysis of the contribution of changes in mRNA stability to the changes in steady-state levels of cyclin mRNA in the mammalian cell cycle. |
CCND3 |
| 72 |
16322284 |
10.1158/1078-0432.CCR-05-1028 |
2005 |
Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma. |
CCND3 |
| 73 |
16620575 |
NA |
2005 |
[Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma]. |
CCND3 |
| 74 |
15096562 |
10.1016/S1525-1578(10)60494-1 |
2004 |
CyclinD1/CyclinD3 ratio by real-time PCR improves specificity for the diagnosis of mantle cell lymphoma. |
CCND3 |
| 75 |
15098007 |
10.1038/modpathol.3800100 |
2004 |
Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma. |
CCND3 |
| 76 |
15305377 |
10.1002/ijc.20354 |
2004 |
Cyclin D3 immunoreactivity in follicular lymphoma is independent of the t(6;14)(p21.1;q32.3) translocation or cyclin D3 gene amplification and is correlated with histologic grade and Ki-67 labeling index. |
CCND3 |
| 77 |
12592386 |
10.1038/sj.onc.1206193 |
2003 |
Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. |
CCND3 |
| 78 |
12647795 |
10.14670/HH-18.449 |
2003 |
Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas. |
CCND3 |
| 79 |
12780788 |
10.1046/j.1365-2141.2003.04354.x |
2003 |
Growth regulation by p27Kip1 is abrogated by multiple mechanisms in aggressive malignant lymphomas. |
CCND3 |
| 80 |
12898595 |
10.1002/path.1384 |
2003 |
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation. |
CCND3 |
| 81 |
11895902 |
NA |
2002 |
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. |
CCND3 |
| 82 |
12036888 |
10.1182/blood.v99.12.4554 |
2002 |
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. |
CCND3 |
| 83 |
12107101 |
10.1016/S0002-9440(10)64168-5 |
2002 |
Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1. |
CCND3 |
| 84 |
12383214 |
10.1046/j.1365-2559.2002.01506.x |
2002 |
Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. |
CCND3 |
| 85 |
11242797 |
10.1309/8KF0-0Y0C-2F4L-UHXL |
2001 |
Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features. |
CCND3 |
| 86 |
11675358 |
10.1182/blood.v98.9.2837 |
2001 |
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. |
CCND3 |
| 87 |
10803523 |
10.1038/sj.leu.2401761 |
2000 |
Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. |
CCND3 |
| 88 |
10896950 |
10.1074/jbc.m001048200 |
2000 |
Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3'-untranslated region of the mRNA. |
CCND3 |
| 89 |
10225442 |
10.1002/(sici)1097-0215(19990517)81:4<543::aid-ijc7>3.0.co;2-3 |
1999 |
Expression of cyclin D2 and D3 in lymphoid lesions. |
CCND3 |
| 90 |
10397744 |
NA |
1999 |
Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. |
CCND3 |
| 91 |
10482983 |
10.1038/sj.leu.2401485 |
1999 |
Selective usage of D-type cyclins in lymphoid malignancies. |
CCND3 |
| 92 |
10597239 |
10.1038/sj.onc.1203162 |
1999 |
Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. |
CCND3 |
| 93 |
10037001 |
10.3109/10428199809059246 |
1998 |
The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. |
CCND3 |
| 94 |
9697879 |
10.1038/sj.leu.2401100 |
1998 |
G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation. |
CCND3 |
| 95 |
9713342 |
10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0 |
1998 |
Cyclin D3 expression in normal, reactive and neoplastic tissues. |
CCND3 |
| 96 |
9099742 |
10.1074/jbc.272.16.10859 |
1997 |
Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. |
CCND3 |
| 97 |
9154817 |
10.1128/MCB.17.6.3181 |
1997 |
Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. |
CCND3 |
| 98 |
9376597 |
NA |
1997 |
Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. |
CCND3 |
| 99 |
8668211 |
10.1128/MCB.16.7.3934 |
1996 |
Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. |
CCND3 |
| 100 |
8959341 |
NA |
1996 |
Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. |
CCND3 |
Datasets
Models
